Literature DB >> 15468293

Coregulators and chromatin remodeling in transcriptional control.

Rakesh Kumar1, Rui-An Wang, Christopher J Barnes.   

Abstract

Despite many years of investigation by numerous investigators, transcriptional regulatory control remains an intensely investigated and continuously evolving field of research. Transcriptional regulation is dependent not only on transcription factor activation and chromatin remodeling, but also on a host of transcription factor coregulators-coactivators and corepressors. In addition to transcription factor activation and chromatin changes, there is an expanding array of additional modifications that titrate transcriptional regulation for the specific conditions of a particular cell type, organ system, and developmental stage, and such events are likely to be greatly influenced by upstream signaling cascades. Here, we will briefly review the highlights and perspectives of chromatin remodeling and transcription controls as affected by cofactor availability, cellular energy state, relative ratios of reducing equivalents, and upstream signaling. We also present the C-terminal binding protein (CtBP) as a novel nuclear receptor (NR) coregulator, which exemplifies the integration of a number of transcriptional regulatory controls. (c) 2004 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2004        PMID: 15468293     DOI: 10.1002/mc.20056

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  9 in total

1.  Functional regulation of oestrogen receptor pathway by the dynein light chain 1.

Authors:  Suresh K Rayala; Petra den Hollander; Seetharaman Balasenthil; Zhibo Yang; Russell R Broaddus; Rakesh Kumar
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

2.  Identification and characterization of ToRC, a novel ISWI-containing ATP-dependent chromatin assembly complex.

Authors:  Alexander V Emelyanov; Elena Vershilova; Maria A Ignatyeva; Daniil K Pokrovsky; Xingwu Lu; Alexander Y Konev; Dmitry V Fyodorov
Journal:  Genes Dev       Date:  2012-03-15       Impact factor: 11.361

Review 3.  Combinatorial control of ATF4-dependent gene transcription in osteoblasts.

Authors:  René St-Arnaud; Bahareh Hekmatnejad
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

4.  Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70.

Authors:  Yi Peng; Caihong X Li; Fei Chen; Zhengxin Wang; Martin Ligr; Jonathan Melamed; Jianjun Wei; William Gerald; Michele Pagano; Michael J Garabedian; Peng Lee
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

5.  Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.

Authors:  Grace Lin; Christopher R LaPensee; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Cell Endocrinol       Date:  2014-08-01       Impact factor: 4.102

Review 6.  Axonal transcription factors: novel regulators of growth cone-to-nucleus signaling.

Authors:  Sheng-Jian Ji; Samie R Jaffrey
Journal:  Dev Neurobiol       Date:  2013-09-30       Impact factor: 3.964

7.  E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.

Authors:  Da-Qiang Li; Kazufumi Ohshiro; Sirigiri Divijendra Natha Reddy; Suresh B Pakala; Mong-Hong Lee; Yanping Zhang; Suresh K Rayala; Rakesh Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-24       Impact factor: 11.205

8.  Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability.

Authors:  Pei-Hong Chen; Yeou-Ping Tsao; Chih-Chiang Wang; Show-Li Chen
Journal:  Nucleic Acids Res       Date:  2007-11-05       Impact factor: 16.971

9.  Molecular characterization of a human matrix attachment region epigenetic regulator.

Authors:  Salina Arope; Niamh Harraghy; Milos Pjanic; Nicolas Mermod
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.